AI Reveals New Discovery in Cardiovascular Disease & Cancer

Yale scientists publish a study in Nature that shows how WuXi NextCODE's AI and genomic analysis technology revealed an unknown cause of cardiovascular disease. WuXi NextCODE today highlighted the contribution of its artificial intelligence (AI) and sequencing teams to the discovery of a novel mechanism regulating how blood vessels grow. The study, "FGF-dependent metabolic control of vascular development," led by Yale University's Michael Simons and including scientists from six countries, is published in the May 2017 edition of Nature. The development of blood vessels is regulated by growth factors. If this development is impaired it can lead to cardiovascular disease; conversely if it is normal or upregulated in cancer, it can contribute to a tumor's rapid growth.